CIK 0001512762 · Accelerated filer<br>Smaller reporting company
Coherus Oncology, Inc.
Sign in to watch- Ticker
- CHRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273615821
- Phone
- (650) 649-3530
- Business address
- C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
- Former names
- Coherus BioSciences, Inc., BioGenerics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-11-20 | Watler Peter K. Chief Technical Officer | Option exercise · Stock Option (right to buy) | −20,000 | 39,988 | ||
| 2015-11-13 | Richards Christos Director | Sale | −7,988 | $27.38 | $219K | 67,848 |
| 2015-11-13 | Richards Christos Director | Sale | −4,012 | $27.93 | $112K | 63,836 |
| 2015-11-12 | Richards Christos Director | Sale | −3,000 | $27.23 | $82K | 75,836 |
| 2015-11-02 | Herman Alan C. Chief Scientific Officer | Option exercise | +18,416 | $0.42 | $8K | 233,115 |
| 2015-11-02 | Herman Alan C. Chief Scientific Officer | Sale | −16,516 | $28.65 | $473K | 216,599 |
| 2015-11-02 | Herman Alan C. Chief Scientific Officer | Sale | −1,900 | $29.25 | $56K | 214,699 |
| 2015-11-02 | Herman Alan C. Chief Scientific Officer | Option exercise · Stock Option (right to buy) | −18,416 | 57,361 | ||
| 2015-10-01 | Herman Alan C. Chief Scientific Officer | Option exercise | +4,250 | $0.42 | $2K | 218,949 |
| 2015-10-01 | Herman Alan C. Chief Scientific Officer | Sale | −3,350 | $18.83 | $63K | 215,599 |
| 2015-10-01 | Herman Alan C. Chief Scientific Officer | Sale | −900 | $19.51 | $18K | 214,699 |
| 2015-10-01 | Herman Alan C. Chief Scientific Officer | Option exercise · Stock Option (right to buy) | −4,250 | 75,777 | ||
| 2015-09-01 | Herman Alan C. Chief Scientific Officer | Option exercise | +11,333 | $0.42 | $5K | 226,032 |
| 2015-09-01 | Herman Alan C. Chief Scientific Officer | Sale | −6,024 | $27.23 | $164K | 220,008 |
| 2015-09-01 | Herman Alan C. Chief Scientific Officer | Sale | −5,309 | $27.57 | $146K | 214,699 |
| 2015-09-01 | Herman Alan C. Chief Scientific Officer | Option exercise · Stock Option (right to buy) | −11,333 | 80,027 | ||
| 2015-08-18 | Wahlstrom Mats Director | Sale | −6,372 | $33.50 | $213K | 578,528 |
| 2015-08-18 | Wahlstrom Mats Director | Sale | −6,373 | $33.50 | $214K | 578,527 |
| 2015-08-17 | Wahlstrom Mats Director | Sale | −8,028 | $33.91 | $272K | 584,900 |
| 2015-08-14 | Wahlstrom Mats Director | Sale | −116,554 | $34.24 | $4.0M | 592,928 |
Page 31 of 39 · 768 trades